Trademark: 79062235
Word
KURADURA
Status
Dead
Status Code
404
Status Date
Wednesday, August 15, 2018
Serial Number
79062235
Registration Number
3807132
Registration Date
Tuesday, June 22, 2010
Mark Type
4000
Filing Date
Friday, August 15, 2008
Published for Opposition
Tuesday, April 6, 2010
Cancellation Date
Wednesday, August 15, 2018

Trademark Owner History
Kuros Biosurgery AG - Original Registrant

Classifications
5 Cosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement
10 Artificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts
KUROS DURA
The wording "KURADURA" has no meaning in a foreign language.

Trademark Events
Mar 15, 2019
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Mar 15, 2019
Death Of International Registration
Jan 25, 2018
Change Of Name/Address Rec'd From Ib
Oct 27, 2017
Total Invalidation Processed By The Ib
Oct 2, 2017
Total Invalidation Of Reg Ext Protection Sent To Ib
Oct 2, 2017
Invalidation Processed
Sep 27, 2017
Total Invalidation Of Reg Ext Protection Created
Jan 27, 2017
Cancelled Section 71
May 18, 2013
Final Decision Transaction Processed By Ib
Sep 24, 2010
Final Disposition Notice Sent To Ib
Sep 24, 2010
Final Disposition Processed
Sep 22, 2010
Final Disposition Notice Created, To Be Sent To Ib
Jun 22, 2010
Registered-Principal Register
Jun 4, 2010
Notification Of Possible Opposition - Processed By Ib
May 20, 2010
Notification Of Possible Opposition Sent To Ib
May 20, 2010
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 6, 2010
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2010
Published For Opposition
Mar 1, 2010
Law Office Publication Review Completed
Feb 25, 2010
Exparte Appeal Terminated
Feb 16, 2010
Approved For Pub - Principal Register
Feb 16, 2010
Teas/Email Correspondence Entered
Feb 16, 2010
Correspondence Received In Law Office
Feb 12, 2010
Teas Request For Reconsideration Received
Feb 12, 2010
Ex Parte Appeal-Instituted
Feb 12, 2010
Jurisdiction Restored To Examining Attorney
Feb 12, 2010
Exparte Appeal Received At Ttab
Aug 17, 2009
Notification Of Final Refusal Emailed
Aug 17, 2009
Final Refusal E-Mailed
Aug 17, 2009
Final Refusal Written
Jul 21, 2009
Teas/Email Correspondence Entered
Jul 21, 2009
Correspondence Received In Law Office
Jul 21, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 21, 2009
Assigned To Lie
Jul 6, 2009
Teas Change Of Correspondence Received
Jul 6, 2009
Teas Response To Office Action Received
Feb 6, 2009
Refusal Processed By Ib
Jan 6, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Jan 6, 2009
Refusal Processed By Mpu
Jan 3, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Jan 2, 2009
Non-Final Action Written
Dec 23, 2008
Application Filing Receipt Mailed
Dec 19, 2008
Assigned To Examiner
Dec 19, 2008
New Application Entered In Tram
Dec 18, 2008
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24